China Money Network
Login
Join

Haisco Pharma Leads $15M Series D In Israeli Start-Up

  • February 11, 2016 — 11:12 CST

This Data Is Locked!

This area is available only to Subscribers.

Shenzhen-listed Chinese pharmaceutical company Haisco Pharmaceutical Group has led a US$15 million series D round of financing in Israeli drug developer Regentis Biomaterials Ltd., says... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: